[
    [
        {
            "time": "2023-06-05",
            "original_text": "医保体系拟建信用评价制度，失信“特别严重”的药企，将暂停全部药品招采挂网资格",
            "features": {
                "keywords": [
                    "医保体系",
                    "信用评价制度",
                    "失信",
                    "药企",
                    "招采挂网资格"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "医保体系拟建信用评价制度，失信“特别严重”的药企，将暂停全部药品招采挂网资格",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-06-05",
            "original_text": "北上资金本周净买入240.51亿元 连续11周净买入",
            "features": {
                "keywords": [
                    "北上资金",
                    "净买入",
                    "连续11周"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金本周净买入240.51亿元 连续11周净买入",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-06-05",
            "original_text": "恒瑞医药受沪股通青睐 连续6日净买入",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "沪股通",
                    "净买入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药受沪股通青睐 连续6日净买入",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-06-05",
            "original_text": "国家医保局将拟医药价格建信用评价制度、全球疫苗峰会筹资超74亿美元、健帆生物控股股东减持",
            "features": {
                "keywords": [
                    "国家医保局",
                    "医药价格",
                    "信用评价制度",
                    "全球疫苗峰会",
                    "健帆生物",
                    "控股股东减持"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国家医保局将拟医药价格建信用评价制度、全球疫苗峰会筹资超74亿美元、健帆生物控股股东减持",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-06-05",
            "original_text": "两大主力资金联手400亿做多A股，科技股屡获加仓",
            "features": {
                "keywords": [
                    "主力资金",
                    "A股",
                    "科技股",
                    "加仓"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "两大主力资金联手400亿做多A股，科技股屡获加仓",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-06-05",
            "original_text": "逾50亿主力资金撤离医药生物行业 近5成个股表现不及大盘",
            "features": {
                "keywords": [
                    "主力资金",
                    "医药生物",
                    "撤离",
                    "大盘"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "逾50亿主力资金撤离医药生物行业 近5成个股表现不及大盘",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-06-05",
            "original_text": "创新药转型趋势十分明显 商业化或成全新增长点",
            "features": {
                "keywords": [
                    "创新药",
                    "转型",
                    "商业化",
                    "增长点"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "创新药转型趋势十分明显 商业化或成全新增长点",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]